Compound ID | 3517

1D10

Class: Bacteriophage and/or bacteriophage-derived product

Agent Type: Direct acting; Bacteriophage or bacteriphage-derived product;
Spectrum of activity: Gram-negative
Mechanism of action: Cell wall active agent (i.e. partial degradation of the peptidoglycan) and membrane-active agent
Target Pathogen: Active against Acinetobacter baumannii (without addition of EDTA to act as sensitizer)
Description: Synthetic bacteriophage lysin; engineered lysin containing a outer-membrane permeabilizing peptide from cecropin A , the cell wall binding domain of bacteriophage ϕKZ, a linker, and an enzymatically active domain of the virion-associated lysin of phage BcepC6B
Year first mentioned: 1999
Development status: Experimental

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.